2025-12-31 - Analysis Report
Okay, here's a comprehensive analysis of Hims & Hers Health Inc. (HIMS) based on the provided data.

**1) Return Rate Comparison (HIMS vs. S&P 500)**

*   **Ticker:** HIMS
*   **Company Overview:** Hims & Hers Health Inc. is a telehealth company that provides personalized health and wellness solutions.
*   **HIMS Cumulative Return:** 113.31%
*   **S&P 500 (VOO) Cumulative Return:** 76.17%
*   **Divergence:** 44.3 (Relative Divergence: 32.0)

**Analysis:**

HIMS has significantly outperformed the S&P 500 over the period examined, with a cumulative return 37.14% higher. The divergence of 44.3 indicates HIMS' performance has exceeded that of the S&P 500. However, the relative divergence of 32.0 suggests this performance is in the lower range of its historical divergence fluctuations. This could indicate potential for further growth relative to the S&P 500, or it could signal that the outperformance is becoming less pronounced.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta  | Cap(B) |
| :----------- | :----- | :----- | :----- | :---- | :------ |
| 2019-2021  | -42.0% | 74.4% | -81.0% | 0.0  | 1.5    |
| 2020-2022  | -19.0% | 78.6% | -18.0% | -0.0 | 1.5    |
| 2021-2023  | -65.0% | 78.6% | -67.0% | -0.1 | 2.0    |
| 2022-2024  | 119.0% | 79.4% | 98.0%  | -0.0 | 5.5    |
| 2023-2025  | 118.0% | 80.8% | 51.0%  | 0.1  | 7.5    |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows volatile performance, with negative returns in early periods and significant positive returns in recent periods.
*   **MDD:** The Maximum Drawdown is consistently high, indicating substantial risk and volatility.
*   **Alpha:** Alpha, representing performance above the benchmark, is mostly negative in earlier years, suggesting underperformance relative to the market on a risk-adjusted basis. More recent periods show strong positive Alpha, indicating significant outperformance.
*   **Beta:** Beta fluctuates around 0, suggesting HIMS's price movement is not strongly correlated with the overall market.
*   **Cap(B):** Market capitalization has increased significantly over time, indicating company growth.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 33.04
*   **Last Market Price:** 33.04, Previous Close: 34.1, Change: -3.11
*   **5-day SMA:** 34.18
*   **20-day SMA:** 36.42
*   **60-day SMA:** 42.35

**Analysis:**

HIMS's current price is below its 5-day, 20-day, and 60-day Simple Moving Averages (SMAs). This suggests a short-term downward trend. The fact that the 5-day SMA is below the 20-day SMA, which is below the 60-day SMA, further confirms this downward momentum. The recent change of -3.11 indicates a significant recent price decrease.

**3) Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 14.61 (Oversold)
*   **PPO:** -0.30
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (27 shares - Very Safe - MRI:0.90) Monthly invest 1.3% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent 20-day Relative Divergence Change:** -1.7 (Short-term decline)
*   **Expected Return (%):** 37.2% (Long-term)

**Analysis:**

*   The high MRI score (0.9) suggests that the investment is currently considered to have a "High Investment Recommended", despite recent volatility.
*   The RSI of 14.61 indicates that the stock is oversold, potentially signaling a buying opportunity.
*   The negative PPO suggests a downward trend.
*   The "Hybrid Signal" recommends buying the stock with 100% of available cash, suggesting a bullish outlook despite the current price decline.
*   The negative change in relative divergence over the past 20 days confirms the short-term downward trend.
*   The Expected Return of 37.2% is high, suggesting significant potential upside if held long-term (over 2 years).

**4) Recent News & Significant Events:**

*   **AI Expansion:** HIMS is scaling AI-enabled care, potentially improving efficiency and patient experience.
*   **Ohio Buildout/Macro Calendar:** Investors are weighing the impact of HIMS's Ohio buildout and broader economic factors.
*   **Share Repurchase Program:** A $250 Million share repurchase program was authorized, which could boost the stock price by reducing the number of shares outstanding.
*   **Canadian Market Expansion:** Investors are considering HIMS's potential expansion into the Canadian market.
*   **2025 Performance:** The stock is up 36% in 2025, indicating strong positive momentum over the year.
*   **Past Months Plunge:** Hims & Hers Plunges 15.6% in 3 Months.

**Analysis:**

The news headlines present a mixed picture. The AI expansion, share repurchase program, and potential Canadian expansion are positive developments. However, investor concerns about the Ohio buildout and macro calendar, as well as the stock's plunge of the past months, create uncertainty.

**4-2) Analyst Opinions:**

*   **Mean:** - (No data)
*   **Opinions:** 12
*   **Target Price (avg/high/low):** 44.67 / 85.00 / 25.00
*   **Recent Rating Changes:** No data

**Analysis:**

Analyst target prices suggest significant upside potential, with an average target of $44.67 versus the current price of $33.04. There is a very wide range of target prices, suggesting differing opinions and uncertainties regarding the stock's future performance.

**5) Recent Earnings Analysis:**

| 날짜       | EPS   | 매출      |
| :--------- | :---- | :-------- |
| 2025-11-03 | 0.07  | 0.60 B$  |
| 2025-08-04 | 0.19  | 0.54 B$  |
| 2025-05-05 | 0.22  | 0.59 B$  |
| 2024-11-04 | 0.35  | 0.40 B$  |
| 2025-11-03 | 0.35  | 0.40 B$  |

**Analysis:**

*   Revenue has generally increased over the past few quarters, indicating growth in the company's business.
*   EPS has fluctuated.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-09-30 | $0.60B   | 73.80%       |
| 2025-06-30 | $0.54B   | 76.39%       |
| 2025-03-31 | $0.59B   | 73.50%       |
| 2024-12-31 | $0.48B   | 76.81%       |
| 2024-09-30 | $0.40B   | 79.16%       |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
| :----------- | :-------- | :-------- |
| 2025-09-30 | $0.58B   | 2.72%     |
| 2025-06-30 | $0.56B   | 7.55%     |
| 2025-03-31 | $0.55B   | 9.01%     |
| 2024-12-31 | $0.48B   | 5.46%     |
| 2024-09-30 | $0.44B   | 17.18%    |

**Analysis:**

*   Revenue has been growing steadily, reflecting increased sales.
*   Profit margins are consistently high, indicating strong pricing power or efficient cost management.
*   Equity has been increasing, signifying a strengthening financial position.
*   ROE has fluctuated but generally remains positive, indicating profitability.

**7) Comprehensive Analysis (Summary):**

Hims & Hers Health Inc. (HIMS) presents a complex investment picture:

*   **Strengths:** HIMS has significantly outperformed the S&P 500, and analysts have a relatively high target price. Revenue and profitability are growing. The high MRI score and Hybrid Signal is positive. The company is expanding into new areas like AI and potentially Canada.
*   **Weaknesses:** The stock is currently in a short-term downward trend, reflected in the moving averages and recent price decline. The MDD is high, suggesting high volatility. The divergence, analyst target range and financial numbers fluctuates largely.
*   **Opportunities:** The oversold RSI could signal a buying opportunity. The high expected return suggests significant long-term upside. Share buybacks could boost the stock price.
*   **Threats:** Investor concerns about the Ohio buildout and broader economic factors, and the past months plunge.

**Conclusion:**

HIMS appears to be a potentially high-reward, high-risk investment. The company has demonstrated strong growth and profitability, but it is also subject to significant volatility and investor concerns. A long-term investment horizon may be necessary to realize the potential upside. Consider the mixed news headlines, current downward price trend, and potential external factors.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.